Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 16;9(2):77-84.
doi: 10.4253/wjge.v9.i2.77.

Clinical utility of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography-related procedures

Yuji Sakai  1 , Toshio Tsuyuguchi  1 , Nobuto Hirata  1 , So Nakaji  1 , Kenji Shimura  1 , Takao Nishikawa  1 , Tatsuya Fujimoto  1 , Tetsuya Hamano  1 , Takayoshi Nishino  1 , Osamu Yokosuka  1
Affiliations

Clinical utility of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography-related procedures

Yuji Sakai et al. World J Gastrointest Endosc. .

Abstract

Aim: To examine the result of the use of 0.025-inch guidewire (GW) VisiGlide2TM as the first choice in the endoscopic retrograde cholangiopancreatography (ERCP)-related procedures without selecting the patient in a multicenter prospective study.

Methods: ERCP using 0.025-inch GW VisiGlide2TM as the first choice was conducted in patients who have needed ERCP, and its accomplishment rate of procedure, procedural time, incidence of accidental symptoms were compared with those of ERCP using 0.025-inch GW VisiGlideTM.

Results: The accomplishment rate of procedure was 97.5% (197/202), and procedural time was 23.930 ± 16.207 min. The accomplishment rate of procedure using 0.025-inch GW VisiGlideTM was 92.3% (183/195), and procedural time was 31.285 ± 19.122 min, thus the accomplishment rate of procedure was significantly improved and procedural time was significantly shortened (P < 0.05). Accidental symptoms by ERCP-related procedures were observed in 3.0% (6/202), and all were conservatively alleviated.

Conclusion: When 0.025-inch GW VisiGlide2TM was used for ERCP-related procedure as the first choice, it showed high accomplishment rate of procedure and low incidence of accidental symptoms, suggesting it can be used as the universal GW. Clinical Trial Registry (UMIN0000016042).

Keywords: 0.025-inch guidewire; Endoscopic retrograde cholangiopancreatography; Endoscopic sphincterotomy.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors have no other disclosures.

Figures

Figure 1
Figure 1
0.025-inch guidewire VisiGlide2TM. The tip of hydrophilic coating is flexible.
Figure 2
Figure 2
Comparison between 0.025-inch guidewire VisiGlide2TM, 0.025-inch guidewire VisiGlideTM, and 0.035 inch guidewire. Although it has thinness of 0.025-inch (0.63 mm), its special processing method ensures rigidity equivalent to that of 0.035 inch (0.89 mm). GW: Guidewire.
Figure 3
Figure 3
Result of use of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography as the first choice. ERCP: Endoscopic retrograde cholangiopancreatography; TPPP: Transpancreatic precut papillotomy; PTGBD: Percutaneous transhepatic gallbladder drainage; GW: Guidewire.
Figure 4
Figure 4
Although it has thinness of 0.025-inch (0.63 mm), its special processing method ensures rigidity equivalent to that of 0.035 inch (0.89 mm). A: 0.025-inch guidewire (GW) VisiGlide2TM placed in the bile duct (arrow)/pancreatic duct (arrow head). The visibility is good under endoscopy; B: 0.025-inch GW VisiGlide2TM placed in the bile duct (arrow)/pancreatic duct (arrow head). The visibility is good under radiography.
Figure 5
Figure 5
Placement of metallic stent using 0.025-inch guidewire VisiGlide2TM. It was possible to break through the stenosis, to induce delivery and to place stents only with this guidewire.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nambu T, Ukita T, Shigoka H, Omuta S, Maetani I. Wire-guided selective cannulation of the bile duct with a sphincterotome: a prospective randomized comparative study with the standard method. Scand J Gastroenterol. 2011;46:109–115. - PubMed
    1. Herreros de Tejada A, Calleja JL, Díaz G, Pertejo V, Espinel J, Cacho G, Jiménez J, Millán I, García F, Abreu L. Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial. Gastrointest Endosc. 2009;70:700–709. - PubMed
    1. Angsuwatcharakon P, Rerknimitr R, Ridtitid W, Ponauthai Y, Kullavanijaya P. Success rate and cannulation time between precut sphincterotomy and double-guidewire technique in truly difficult biliary cannulation. J Gastroenterol Hepatol. 2012;27:356–361. - PubMed
    1. Youn YH, Lim HC, Jahng JH, Jang SI, You JH, Park JS, Lee SJ, Lee DK. The increase in balloon size to over 15 mm does not affect the development of pancreatitis after endoscopic papillary large balloon dilatation for bile duct stone removal. Dig Dis Sci. 2011;56:1572–1577. - PMC - PubMed
    1. Osanai M, Maguchi H, Takahashi K, Katanuma A, Yane K, Kaneko M, Hashigo S, Katoh S, Harada R, Katoh R, et al. Safety and long-term outcomes of endoscopic papillary balloon dilation in children with bile duct stones. Gastrointest Endosc. 2011;73:619–623. - PubMed

LinkOut - more resources